Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
More unhealthy behaviour among young people; their health remains vulnerable Fewer young people aged 12 to 16 are positive about their health than in previous years. In addition, their mental health has not recovered after the COVID-19 pandemic.
Remove ticks quickly, reduce your risk of Lyme disease Ticks are active again, as shown by the increase in tick bite reports on Tekenradar.nl. Quick action is important: the faster you remove a tick after it bites you, the lower your risk of contracting Lyme disease.
RIVM recommends a standardised design for e-cigarettes to reduce e-cigarette appeal Features like a sleek design, technical add-ons such as Bluetooth, and ease of concealment are examples that make e-cigarettes attractive to young people, according to research by RIVM. That is why RIVM recommends policymakers to consider implementing a standardised design for e-cigarettes
Air pollution increases risk of infection and severity of illness from COVID-19 People who live in areas with poor air quality are more likely to become infected with SARS-CoV-2. Moreover, the symptoms of COVID-19 are more severe, leading to more hospitalisations and deaths. This is the outcome of a study conducted by RIVM, Utrecht University, Wageningen University & Research and the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters.
Nitrogen and nature approach shows progress towards 2030, but targets are out of reach The nitrogen and nature measures that the government has implemented since 2021 are expected to make a positive contribution to the future quality of nature. The average exceedance of the critical loads for nitrogen deposition will decrease by a third up to 2030.
More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.
Dutch population’s salt and sugar intakes go down, fibre intake goes up On average, the sugar and salt intakes of the Dutch population have gone down, while its fibre intake has gone up. This is apparent from the latest Dutch National Food Consumption Survey (Voedselconsumptiepeiling, VCP) figures.
Booster vaccinations reduced risk of death from COVID-19 in 2022 Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.
RIVM identifies three major challenges for public health and healthcare in period to 2050 The Dutch public health and healthcare will face three crucial challenges in the period to 2050. This is according to RIVM’s preview of the Dutch Public Health Foresight Study 2024.